About EAVE II
An introduction to the project: the vision, the team, our history, our protocol, funders and partners.
An Introduction to EAVE II
Using patient data to track the COVID-19 pandemic and vaccine effectiveness across Scotland.
All Things Data
The EAVE II dataset is being used to track COVID-19 across Scotland, to identify those at highest risk of severe COVID-19 outcomes and investigate vaccine effectiveness and safety. It is therefore an essential resource in Scotland’s response to the pandemic.
Meet the team
Discover our academic researchers and public advisory group.
The History of EAVE II
EAVE began as a study on pandemic swine flu in Scotland, quickly adapting to become EAVE II for analysing and monitoring COVID-19.
Funders and partners
This work is funded by the Medical Research Council, led by the University of Edinburgh in collaboration with University of Strathclyde, Public Health Scotland, West of Scotland Specialist Virology Centre and University of Aberdeen.
EAVE II is involved and connected with various other projects from across the UK.
Protocol and analysis
The EAVE II team is committed to openness and transparency. Key information such as the study protocol, statistical analysis plan and code used in analyses are available on this website.